SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-19-062059
Filing Date
2019-11-12
Accepted
2019-11-12 07:41:58
Documents
108
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm1919588d1_10q.htm 10-Q 1604563
2 EXHIBIT 31.1 tm1919588d1_31-1.htm EX-31.1 10728
3 EXHIBIT 31.2 tm1919588d1_31-2.htm EX-31.2 10600
4 EXHIBIT 32.1 tm1919588d1_32-1.htm EX-32.1 4192
5 EXHIBIT 32.2 tm1919588d1_32-2.htm EX-32.2 4173
  Complete submission text file 0001104659-19-062059.txt   14865035

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT fbio-20190930.xml EX-101.INS 4700844
7 XBRL TAXONOMY EXTENSION SCHEMA fbio-20190930.xsd EX-101.SCH 120457
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fbio-20190930_cal.xml EX-101.CAL 130678
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fbio-20190930_def.xml EX-101.DEF 371224
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE fbio-20190930_lab.xml EX-101.LAB 743657
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fbio-20190930_pre.xml EX-101.PRE 689681
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 781-652-4500
Fortress Biotech, Inc. (Filer) CIK: 0001429260 (see all company filings)

IRS No.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35366 | Film No.: 191206133
SIC: 2834 Pharmaceutical Preparations